Exact FDA event identifier

Event 82718

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: April 26, 2019
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Advanced Pharma Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10

D-1251-2019

Recall number: D-1251-2019
Initiated: April 26, 2019
Classification: Class II
Status: Terminated
Recalling firm: Advanced Pharma Inc.
Quantity: 560 bags

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Sub-potency

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Sub-potency

Code information

Lot: 01/14/19 0215 22110P Exp. 04/29/2019

Distribution pattern

Nationwide in the US